We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCO icon
1926
Columbus McKinnon
CMCO
$584M
$1.94M ﹤0.01%
40,037
+1,171
+3% +$53K
KELYA icon
1927
Kelly Services Class A
KELYA
$528M
$1.93M ﹤0.01%
102,053
-8,710
-8% -$182K
KDMN
1928
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.93M ﹤0.01%
221,080
+4,907
+2% +$27.9K
SLCA
1929
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$1.92M ﹤0.01%
240,681
-8,844
-4% -$83.7K
JAMF
1930
DELISTED
Jamf
JAMF
$1.92M ﹤0.01%
49,877
+1,775
+4% +$60.9K
MYE icon
1931
Myers Industries
MYE
$1.29B
$1.92M ﹤0.01%
97,853
-14,223
-13% -$303K
JOUT icon
1932
Johnson Outdoors
JOUT
$505M
$1.91M ﹤0.01%
18,077
+6,848
+61% +$782K
GEVO icon
1933
Gevo
GEVO
$382M
$1.9M ﹤0.01%
286,693
+7,375
+3% +$45.6K
UHT
1934
Universal Health Realty Income Trust
UHT
$594M
$1.9M ﹤0.01%
34,431
-4,690
-12% -$276K
SILK
1935
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.9M ﹤0.01%
34,495
+1,353
+4% +$70.8K
SYBT icon
1936
Stock Yards Bancorp
SYBT
$2.6B
$1.9M ﹤0.01%
32,335
+2,518
+8% +$129K
CUTR
1937
DELISTED
Cutera, Inc.
CUTR
$1.89M ﹤0.01%
40,550
-8,618
-18% -$425K
PRIM icon
1938
Primoris Services
PRIM
$4.45B
$1.89M ﹤0.01%
77,048
+1,891
+3% +$50.8K
SANA icon
1939
Sana Biotechnology
SANA
$980M
$1.88M ﹤0.01%
83,649
+59,808
+251% +$1.26M
BLUE
1940
DELISTED
bluebird bio
BLUE
$1.88M ﹤0.01%
7,605
+67
+0.9% +$19.2K
CMO
1941
DELISTED
Capstead Mortgage Corp.
CMO
$1.88M ﹤0.01%
281,233
-36,317
-11% -$238K
IRTC icon
1942
iRhythm Holdings
IRTC
$4.2B
$1.88M ﹤0.01%
32,111
+92
+0.3% +$4.88K
MVIS icon
1943
Microvision
MVIS
$78.9M
$1.88M ﹤0.01%
11,341
-44
-0.4% -$9.17K
UI icon
1944
Ubiquiti
UI
$34.3B
$1.88M ﹤0.01%
6,286
+221
+4% +$68.3K
UTL icon
1945
Unitil
UTL
$980M
$1.88M ﹤0.01%
43,839
-4,261
-9% -$213K
HCKT icon
1946
Hackett Group
HCKT
$287M
$1.87M ﹤0.01%
95,319
+15,320
+19% +$287K
BRMK
1947
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$1.87M ﹤0.01%
189,430
+4,671
+3% +$48.5K
LADR
1948
Ladder Capital
LADR
$1.24B
$1.86M ﹤0.01%
168,816
+5,728
+4% +$64.1K
SWTX
1949
DELISTED
SpringWorks Therapeutics
SWTX
$1.86M ﹤0.01%
29,388
+928
+3% +$71.5K
CDE icon
1950
Coeur Mining
CDE
$17.9B
$1.85M ﹤0.01%
300,602
-12,597
-4% -$89.5K

Similar funds

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.